Minimal Patient-Reported Side Effects for a Chemoablative Gel (UGN-102) Used as Frontline Treatment in Adults with Nonmuscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Minimal Patient-Reported Side Effects for a Chemoablative Gel (UGN-102) Used as Frontline Treatment in Adults with Nonmuscle-Invasive Bladder Cancer

Published:2022-09 Issue:3 Volume:208 Page:580-588
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Stover Angela M.¹²^ORCID,Basak Ramsankar³,Mueller Dana²,Lipman Robert⁴,Teal Randall²⁵,Hilton Alison²⁵,Giannone Kara²⁵,Waheed Myra²⁵,Smith Angela B.²⁶

Affiliation:

1. Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

2. Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

3. Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

4. Bladder Cancer Advocacy Network, Bethesda, Maryland

5. Connected Health Applications & Interventions (CHAI) Core, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

6. Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000002747

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside;Applied Materials Today;2024-08

2. Primary Chemoablation for Intermediate-risk Low-grade Bladder Cancer: New Paradigm or Added Uncertainty?;Journal of Urology;2023-11

3. Novel Delivery Mechanisms for Existing Systemic Agents and Emerging Therapies in Bladder Cancer;Bladder Cancer;2023-06-27

4. Injectable Thermoresponsive Hydrogels for Cancer Therapy: Challenges and Prospects;Gels;2023-05-16

5. A Systematic Review and Meta-analysis of Chemoablation for Non–muscle-invasive Bladder Cancer;European Urology Focus;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3